Colgate-Palmolive Company: Q1 2026 10-Q Summary
Business Context and Reporting Period
This filing covers the quarterly period ended March 31, 2026. Colgate-Palmolive operates in two primary segments: Oral, Personal and Home Care, and Pet Nutrition (Hill's). The quarter reflects the impact of a new segment realignment effective March 31, 2026, combining Europe and Africa/Eurasia into a single EMEA segment. The company continues to execute its 2030 strategy, supported by an expanded "Strategic Growth and Productivity Program."
Key Financial Metrics
| Metric | Q1 2026 | Q1 2025 | Change |
|---|---|---|---|
| Net Sales | $5,324 million | $4,911 million | +8.4% |
| Organic Sales Growth | 2.9% | — | — |
| Gross Profit | $3,226 million | $2,987 million | +8.0% |
| Gross Margin | 60.6% | 60.8% | -20 bps |
| Operating Profit | $964 million | $1,076 million | -10.4% |
| Net Income (Attributable to Colgate) | $646 million | $690 million | -6.4% |
| Diluted EPS | $0.80 | $0.85 | -5.9% |
| Operating Cash Flow | $747 million | $600 million | +24.5% |
| Total Debt | $7,973 million | $7,988 million (Dec 2025) | -0.2% |
| Cash & Equivalents | $1,335 million | $1,288 million (Dec 2025) | +3.6% |
Material Changes vs. Prior Period
- Revenue Drivers: Net sales growth of 8.4% was driven by positive foreign exchange (+5.1%), net selling price increases (+2.2%), and volume growth (+1.1%). Organic sales grew 2.9%.
- Profitability Pressure: GAAP operating profit declined 10% primarily due to $176 million in pre-tax charges from the Strategic Growth and Productivity Program. Excluding these charges and prior-year ERISA litigation costs, non-GAAP operating profit increased 4%.
- Margin Compression: Gross margin decreased 20 basis points due to significantly higher raw and packaging material costs (including tariffs), partially offset by cost savings initiatives and pricing.
- Segment Performance:
- Latin America: Strongest performer with 14.8% sales growth and 15% operating profit growth.
- North America: Sales declined 1.8% and operating profit fell 28% due to volume declines in toothpaste and liquid hand soap.
- Hill's Pet Nutrition: Sales up 6.7% and operating profit up 8%, aided by the Prime100 acquisition.
Guidance, Outlook, and Risks
- Strategic Program Expansion: The Board approved an expansion of the Strategic Growth and Productivity Program. Cumulative pre-tax charges are now estimated between $350 million and $550 million (increased from $200-$300 million), with annualized pre-tax savings projected at $200-$300 million.
- Outlook: Management expects challenging macroeconomic conditions to persist, including inflationary pressures, geopolitical tensions (Middle East, Ukraine), and trade relations (tariffs). They anticipate softness in category growth to continue into 2026.
- Capital Allocation: The quarterly dividend was increased to $0.53 per share. The company repurchased approximately $306 million of treasury stock in Q1. Capital expenditures are expected to be approximately 3.0% of Net sales for 2026.
- Legal Contingencies: Significant ongoing matters include Brazilian tax proceedings (potential exposure ~$103 million) and talcum powder litigation (484 cases pending as of March 31, 2026). The ERISA litigation was settled for $332 million in late 2025.
Investor Verification Checklist
- Restructuring Impact: Verify the cash timing of the expanded $350-$550 million restructuring charge and its impact on future free cash flow.
- Input Costs: Monitor raw material and packaging cost trends, specifically the impact of tariffs on gross margins in North America.
- North America Volume: Assess the sustainability of volume declines in the North American toothpaste and liquid hand soap categories.
- Foreign Exchange: Evaluate the sensitivity of future earnings to currency fluctuations, particularly in hyper-inflationary economies (Argentina, Nigeria, Turkey).
- Legal Exposure: Track developments in the Brazilian tax cases and talcum powder litigation for potential changes in accruals.